Editorial draft for review. Five areas worth watching are access to sequencing, reproductive carrier screening, variant reclassification, genetics-informed treatment, and new interpretation tools. More testing does not automatically mean more useful information. Before pursuing a test, ask what question it can answer, what its limitations are, and whether the result would change care. Carrier screening may help inform reproductive decisions, but it does not identify every possible condition. Uncertain variants are not diagnoses, and classifications may change as evidence grows. Genetics can guide some treatment and screening decisions when considered alongside the clinical picture. New tools, including AI, still require careful validation and clinical judgment. Educational information only; not individualized medical advice.